Rheumatoid nodule

Jump to navigation Jump to search
Rheumatoid nodule

WikiDoc Resources for Rheumatoid nodule

Articles

Most recent articles on Rheumatoid nodule

Most cited articles on Rheumatoid nodule

Review articles on Rheumatoid nodule

Articles on Rheumatoid nodule in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Rheumatoid nodule

Images of Rheumatoid nodule

Photos of Rheumatoid nodule

Podcasts & MP3s on Rheumatoid nodule

Videos on Rheumatoid nodule

Evidence Based Medicine

Cochrane Collaboration on Rheumatoid nodule

Bandolier on Rheumatoid nodule

TRIP on Rheumatoid nodule

Clinical Trials

Ongoing Trials on Rheumatoid nodule at Clinical Trials.gov

Trial results on Rheumatoid nodule

Clinical Trials on Rheumatoid nodule at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Rheumatoid nodule

NICE Guidance on Rheumatoid nodule

NHS PRODIGY Guidance

FDA on Rheumatoid nodule

CDC on Rheumatoid nodule

Books

Books on Rheumatoid nodule

News

Rheumatoid nodule in the news

Be alerted to news on Rheumatoid nodule

News trends on Rheumatoid nodule

Commentary

Blogs on Rheumatoid nodule

Definitions

Definitions of Rheumatoid nodule

Patient Resources / Community

Patient resources on Rheumatoid nodule

Discussion groups on Rheumatoid nodule

Patient Handouts on Rheumatoid nodule

Directions to Hospitals Treating Rheumatoid nodule

Risk calculators and risk factors for Rheumatoid nodule

Healthcare Provider Resources

Symptoms of Rheumatoid nodule

Causes & Risk Factors for Rheumatoid nodule

Diagnostic studies for Rheumatoid nodule

Treatment of Rheumatoid nodule

Continuing Medical Education (CME)

CME Programs on Rheumatoid nodule

International

Rheumatoid nodule en Espanol

Rheumatoid nodule en Francais

Business

Rheumatoid nodule in the Marketplace

Patents on Rheumatoid nodule

Experimental / Informatics

List of terms related to Rheumatoid nodule

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


A rheumatoid nodule is a collection of normal cells including lymphocytes, and fibroblasts that surround a center of fibrinoid necrosis. They are usually subcutaneous especially over boney prominences such in the olecranon. About 5% of rheumatoid arthritis patients have such nodules within 2 years of disease onset, and the cumulative prevalence is about 25%.[1]

Rheumatoid lung nodules

Rheumatoid lung nodules must be differentiated from other cavitary lung lesions.

Causes of

lung cavities

Differentiating Features Differentiating radiological findings Diagnosis

confirmation

  • CXR and CT demonstrates cavities in the upper lobe of the lung
  • Sputum smear positive for acid-fast bacilli and nucleic acid amplification tests (NAAT) is used on sputum or any sterile fluid for rapid diagnosis and is positive for mycobacteria.
  • Any age group
  • Acute, fulminant life threating complication of prior infection
  • >100.4 °F fever, with hemodynamic instability
  • Worsening pneumonia-like symptoms
  • CBC is positive for causative organism
  • Children and elderly are at risk
  • Empyema appears lenticular in shape and has a thin wall with smooth luminal margins
  • Pulmonary nodules with cavities and infiltrates are a frequent manifestation on CXR
  • Elderly females of 40-50 age group
  • Manifestation of rheumatoid arthritis
  • Presents with other systemic symptoms including symmetric arthritis of the small joints of the hands and feet with morning stiffness are common manifestations
  • Pulmonary nodules with cavitation are located in the upper lobe (Caplan syndrome) on X-ray
  • On CXR bilateral adenopathy and coarse reticular opacities are seen
  • CT of the chest demonstrates extensive hilar and mediastinal adenopathy
  • Additional findings on CT include fibrosis (honeycomb, linear, or associated with bronchial distortion), pleural thickening, and ground-glass opacities.[8]
  • Common appearance on CT is patchy consolidation,often accompanied by ground-glass opacities and nodules.[12]
  • Exclusively afflicts smokers, with a peak age of onset of between 20 and 40 years
  • Clinical presentation varies, but symptoms generally include months of dry cough, fever, night sweats, and weight loss
  • Skin is involved in 80% of the cases, scaly erythematous rash is typical
  • Thin-walled cystic cavities are the usual radiographic manifestation, observed in over 50% of patients by either CXR or CT scans.[14]
  • Biopsy of the lung

References

  1. Carmona L, González-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmartí R (2003). "Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity". Ann. Rheum. Dis. 62 (9): 897–900. PMC 1754657. PMID 12922967. Unknown parameter |month= ignored (help).
  2. 2.0 2.1 Chaudhuri MR (1973). "Primary pulmonary cavitating carcinomas". Thorax. 28 (3): 354–66. PMC 470041. PMID 4353362.
  3. Mouroux J, Padovani B, Elkaïm D, Richelme H (1996). "Should cavitated bronchopulmonary cancers be considered a separate entity?". Ann. Thorac. Surg. 61 (2): 530–2. doi:10.1016/0003-4975(95)00973-6. PMID 8572761.
  4. Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM (2005). "Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome". Radiology. 237 (1): 342–7. doi:10.1148/radiol.2371041650. PMID 16183941.
  5. 5.0 5.1 Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
  6. Lee KS, Kim TS, Fujimoto K, Moriya H, Watanabe H, Tateishi U, Ashizawa K, Johkoh T, Kim EA, Kwon OJ (2003). "Thoracic manifestation of Wegener's granulomatosis: CT findings in 30 patients". Eur Radiol. 13 (1): 43–51. doi:10.1007/s00330-002-1422-2. PMID 12541109.
  7. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R (2001). "Clinical characteristics of patients in a case control study of sarcoidosis". Am. J. Respir. Crit. Care Med. 164 (10 Pt 1): 1885–9. doi:10.1164/ajrccm.164.10.2104046. PMID 11734441.
  8. Brauner MW, Grenier P, Mompoint D, Lenoir S, de Crémoux H (1989). "Pulmonary sarcoidosis: evaluation with high-resolution CT". Radiology. 172 (2): 467–71. doi:10.1148/radiology.172.2.2748828. PMID 2748828.
  9. Murphy J, Schnyder P, Herold C, Flower C (1998). "Bronchiolitis obliterans organising pneumonia simulating bronchial carcinoma". Eur Radiol. 8 (7): 1165–9. doi:10.1007/s003300050527. PMID 9724431.
  10. 10.0 10.1 Al-Ghanem S, Al-Jahdali H, Bamefleh H, Khan AN (2008). "Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review". Ann Thorac Med. 3 (2): 67–75. doi:10.4103/1817-1737.39641. PMC 2700454. PMID 19561910.
  11. Cordier JF, Loire R, Brune J (1989). "Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients". Chest. 96 (5): 999–1004. PMID 2805873.
  12. Lee KS, Kullnig P, Hartman TE, Müller NL (1994). "Cryptogenic organizing pneumonia: CT findings in 43 patients". AJR Am J Roentgenol. 162 (3): 543–6. doi:10.2214/ajr.162.3.8109493. PMID 8109493.
  13. Suri HS, Yi ES, Nowakowski GS, Vassallo R (2012). "Pulmonary langerhans cell histiocytosis". Orphanet J Rare Dis. 7: 16. doi:10.1186/1750-1172-7-16. PMC 3342091. PMID 22429393.
  14. Moore AD, Godwin JD, Müller NL, Naidich DP, Hammar SP, Buschman DL, Takasugi JE, de Carvalho CR (1989). "Pulmonary histiocytosis X: comparison of radiographic and CT findings". Radiology. 172 (1): 249–54. doi:10.1148/radiology.172.1.2787035. PMID 2787035.


Template:WH Template:WS